Preclinical models effective in studying molecular mechanisms by which estrogen stimulates tumor proliferation and development of endocrine resistance in ER + breast cancer have concluded that the cross talk between growth factors might be significant in development of resistance to therapy [ 26 ].
← all excerpts
The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast.
1
—
—